Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities

Inflammation

Volumn 35, Issue 2, 2012, Pages 560-565

  Mathema, Vivek Bhakta ^a,d   Koh, Young Sang ^a   Thakuri, Balkrishna Chand ^b   Sillanpää, Mika ^c  

^a Jeju National University School of Medicine   (South Korea)

^b TRIBHUVAN UNIVERSITY   (Nepal)

^c LAPPEENRANTA UNIVERSITY OF TECHNOLOGY   (Finland)

^d Jeju National University   (South Korea)

Author keywords

Anti cancer; Apoptosis; Cytochrome c; Feverfew; Inflammasome; Parthenolide; ROS; TCP

Indexed keywords

CELL PROTEIN; CYTOCHROME C; HISTONE DEACETYLASE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; PARTHENOLIDE; PROTEIN TCP; REACTIVE OXYGEN METABOLITE; STAT PROTEIN; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL SPECIFICITY; DNA SYNTHESIS INHIBITION; DRUG MECHANISM; DRUG SENSITIZATION; DRUG STRUCTURE; ENZYME INHIBITION; GENE REPRESSION; HUMAN; MICROTUBULE ASSEMBLY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; SIGNAL TRANSDUCTION; THROMBOCYTOPOIESIS; TRANSCRIPTION REGULATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; CYTOCHROMES C; HUMANS; I-KAPPA B KINASE; INFLAMMATION; NEOPLASMS; NF-KAPPA B; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES; SESQUITERPENES; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TANACETUM PARTHENIUM; TRANSCRIPTION, GENETIC;

TANACETUM PARTHENIUM;

EID: 84863619176     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9346-0     Document Type: Article

References (59)

1. Marles, R.J., L. Pazos-Sanou, C.M. Compadre, J.M. Pezzuto, E. Bloszyk, and J. Arnason. 1995. Sesquiterpene lactones revisited: recent developments in the assessment of biological activities and structure relationships. Recent Advances in Phytochemistry 29: 333-356.
2. Smolinski, A.T., and J.J. Pestka. 2005. Comparative effects of the herbal constituent parthenolide (Feverfew) on lipopolysaccharide-induced inflammatory gene expression in murine spleen and liver. Journal of Inflammation 2: 1-6.
3. Baud, V., and M. Karin. 2009. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nature Reviews Drug Discovery 8: 33-40.
4. Karin, M., and Y.B. Beriah. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa] B activity. Annual Review Immunology 18: 621-663. (Pubitemid 30365393)
5. WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-β or TNF-α on activated hepatic stellate cells. European Journal of Cell Biology 80: 554-561.
6. Tapia, P.C. 2006. Sublethal mitochondrial stress with an attendant stoichiometric augmentation of reactive oxygen species may precipitate many of the beneficial alterations in cellular physiology produced by caloric restriction, intermittent fasting, exercise and dietary phytonutrients: "Mitohormesis" for health and vitality. Meidical Hypotheses 66: 832-843.
7. Payne, C.M., C. Weber, C.C. Skillicorn, K. Dovrak, H. Bernstein, H. Holubec, et al. 2007. Deoxycholate induces mitochondrial oxidative stress and activates NF-kB through multiple mechanisms in HCT-116 colon epithelial cells. Carcinogenesis 28: 215-222. (Pubitemid 44942646)
8. Li, N., and M. Karin. 1998. Ionizing radiation and short wave-length UV activate NF-κB through two distinct mechanisms. Proceedings of the National Academy of Sciences 95: 13012-13017. (Pubitemid 28509515)
9. Zhang, S., C.N. Ong, and H.M. Shen. 2004. Critical roles of intracellular thiols and calcium in parthenolide-induced apoptosis in human colorectal cancer cells. Cancer Letters 208: 143-153. (Pubitemid 38624155)
10. Tacchini, L., C. DePonti, E. Matteucci, R. Follis, and M.A. Desiderio. 2004. Hepatocyte growth factor-activated NF-kappaB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines. Carcinogenesis 25: 2089-2100. (Pubitemid 39534845)
11. Zhao, L.J., Y.H. Xu, and Y. Li. 2009. Effect of parthenolide on proliferation and apoptosis in gastric cancer cell line SGC7901. Journal of Digestive Disorder 10: 172-180.
12. Benjamin, H.B., B.K. Kwoka, M.K. Ndubuisia, M. Elofssona, and C.M. Crews. 2001. The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IêB kinase. Chemical Biology 8: 759-766. (Pubitemid 32752455)
13. Dai, Y., M.L. Guzman, S. Chen, L. Wang, S.K. Yeung, X.Y. Pei, et al. 2010. The NF (nuclear factor)-eκB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cells. British Journal of Haematology 151: 70-83.
14. Jenkins, C., S. Hewamana, A. Gilkes, S. Neelakantan, P. Crooks, K. Mills, et al. 2008. Nuclear factor-kappaB as a potential therapeutic target for the novel cytotoxic agent LC-1 in acute myeloid leukaemia. British Journal of Hematology 143: 661-671.
15. Hewamana, S., T.T. Lin, C. Jenkins, A.K. Burnett, C.T. Jordan, C. Fegan, et al. 2008. The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine. Clinical Cancer Research 14: 8102-8111.
16. Marfurt, J., F. Chalfein, P. Prayoga, F. Wabiser, E. Kenangalem, and K.A. Piera. 2011. Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax. Antimicrobial Agents and Chemotherapy 55: 96-66.
17. Lamkanfi, M., and V.M. Dixit. 2009. The inflammasomes. PLoS Pathogen 5: e1000510.
18. Rajan, J.V., D. Rodriguez, E.A. Miao, and A. Aderem. 2011. The NLRP3 inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus infection. The Journal of Virology 85: 4167-4172.
19. Pelegrin, P., and A. Surprenant. 2009. The P2X7 receptor-pannexin connection to dye uptake and IL-1β release. Purinergic Signal 5: 129-137.
20. Martinon, F., A. Mayor, and J. Tschopp. 2009. The inflammasomes: guardians of the body. Annual Review of Immunology 27: 229-265.
21. Hornung, V., F. Bauernfeind, A. Halle, E.O. Samstad, H. Kono, K. L. Rock, et al. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Natural Immunology 9: 847-856.
22. Cassel, S.L., S.C. Eisenbarth, S.S. Iyer, J.J. Sadler, O.R. Colegio, L.A. Tephly, et al. 2008. The Nalp3 inflammasome is essential for the development of silicosis. Proceedings of the National Academy of Sciences 105: 9035-9040.
23. Martinon, F., V. Petrilli, A. Mayor, A. Tardivel, and J. Tschopp. 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241. (Pubitemid 43372104)
24. Juliana, C., T. Fernandes-Alnemri, J. Wu, P. Datta, L. Solorzano, J. W. Yu, et al. 2010. Anti-inflammatory compounds parthenolide and bay 11-7082 are direct inhibitors of the inflammasome. The Journal of Biological Chemistry 285: 9792-9802.
25. Dinarello, C.A. 1998. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. International Reviews of Immunolology 16: 457-499. (Pubitemid 28286181)
26. Steele, A.J., D.T. Jones, K. Ganeshaguru, V.M. Duke, B.C. Yogashangary, J.M. North, et al. 2006. The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia 20: 1073-1079. (Pubitemid 43797300)
27. Herrera, F., V. Martin, J. Rodriguez-Blanco, G. García-Santos, I. Antolín, and C. Rodriguez. 2005. Intracellular redox state regulation by parthenolide. Biochemical and Biophysical Research Communications 332: 321-325. (Pubitemid 40724980)
28. Hampton, M.B., and S. Orrenius. 1998. Redox regulation of apoptotic cell death. Biofactors 8: 1-5. (Pubitemid 28332776)
29. Nakshatri, H., S.E. Rice, and P.B. Nakshatri. 2004. Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase. Oncogene 23: 7330-7344. (Pubitemid 39382136)
30. Winterbourn, C.C., and M.B. Hampton. 2008. Thiol chemistry and specificity in redox signaling. Free Radical Biology and Medicine 45: 549-561.
31. Lee, H., M.K. Cha, and I.H. Kim. 2000. Activation of thiol-dependent antioxidant activity of human serum albumin by alkaline pH is due to the B-like conformational change. Archives of Biochemistry and Biophysics 380: 309-318. (Pubitemid 30659101)
32. Pajak, B., B. Gajkowska, and A. Orzechowski. 2008. Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells. Folia Histochemica et Cytobiologica 46: 129-135.
33. Sun, Y., D.K. St Clair, Y. Xu, P.A. Crooks, and W.H. StClair. 2010. A NADPH oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cells. Cancer Research 70: 2880-2890.
34. Zunino, S.J., J.M. Ducore, and D.H. Storms. 2007. Parthenolide induces significant apoptosis and production of reactive oxygen species in high-risk pre-B leukemia cells. Cancer Letters 254: 119-127. (Pubitemid 47058812)
35. Zhang, S., C.N. Ong, and H.M. Shen. 2004. Involvement of proapoptotic bcl-2 family members in parthenolide-induced mitochondrial dysfunction and apoptosis. Cancer Letters 211: 175-188. (Pubitemid 38824631)
36. Li, H., H. Zhu, C.J. Xu, and J. Yuan. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501. (Pubitemid 28391865)
37. Sahler, J., J.J. Bernard, S.L. Spinelli, N. Blumberg, and R.P. Phipps. 2011. The Feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-κB inhibition. Thrombosis Research 27: 426-434.
38. O'Brien, J.J., C.J. Baglole, T.M. Bates, N. Blumberg, C.W. Francis, and R.P. Phipps. 2009. 15-Deoxy-delta12, 14 prostaglandin J2-induced heme oxygenase-1 in megakaryocytes regulates thrombopoiesis. Journal of Thrombosis and Haemostasis 7: 182-189.
39. Weng, S.X., M.H. Sui, S.C. Wang, G. Xu, J. Ma, J. Shan, et al. 2009. Parthenolide inhibits proliferation of vascular smooth muscle cells through induction of G0/G1 phase cell cycle arrest. Journal of Zhejiang University 10: 528-535.
40. Meyer, T., and U. Vinkemeier. 2007. STAT nuclear translocation: potential for pharmacological intervention. Expert Opinion on Therapeutic Targets 11: 1355-1365. (Pubitemid 47610289)
41. Carlisi, D., A. D'Anneo, L. Angileri, M. Lauricella, S. Emanuele, A. Santulli, et al. 2011. Parthenolide sensitizes hepatocellular carcinoma cells to trail by inducing the expression of death receptors through inhibition of STAT3 activation. Journal of Cellular Physiololgy 226: 1632-1641.
42. Guzman, M.L., R.M. Rossi, L. Karnischky, X. Li, D.R. Peterson, D.S. Howard, et al. 2005. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 105: 4163-4169. (Pubitemid 40720758)
43. Ganten, T.M., T.L. Haas, J. Sykora, H. Stahl, M.R. Sprick, S.C. Fas, et al. 2004. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Cell Death and Differenciation 11: S86-S96. (Pubitemid 39136801)
44. Chen, K.F., W.T. Tai, T.H. Liu, H.P. Huang, Y.C. Lin, C.W. Shiau, et al. 2010. Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3. Clinical Cancer Research 16: 5189-5199.
45. Sobota, R., M. Szwed, A. Kasza, M. Bugno, and T. Kordula. 2002. Parthenolide Inhibits activation of signal transducers and activators of transcription (STATs) induced by cytokines of the IL-6 family. Biochemical and Biophysical Research Communications 267: 329-333.
46. Burton, P.R. 1966. A Comparative electron microscopic study of cytoplasmic microtubules and axial unit tubules in a spermatozoon and a protozoan. Journal of Morphology 120: 397-423.
47. Fonrose, X., A. Frédéric, E. Soleilhac, B. David, I. Pouny, J.C. Cintrat, et al. 2007. Parthenolide inhibits tubulin carboxypeptidase activity. Cancer Research 67: 3371-3378. (Pubitemid 46724877)
48. Zhou, J., and P. Giannakakou. 2005. Targeting microtubules for cancer chemotherapy. Current Medicinal Chemistry-Anti-Cancer Agents 5: 65-71. (Pubitemid 40081295)
49. Mialhe, A., L. Lafanechere, and I. Treilleux. 2001. Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis. Cancer Research 61: 5024-5027. (Pubitemid 32681530)
50. Kato, C., K. Miyazaki, and A. Nakagawa. 2004. Low expression of human tubulin tyrosine ligase and suppressed tubulin tyrosination/detyrosination cycle are associated with impaired neuronal differentiation in neuroblastomas with poor prognosis. International Journal of Cancer 112: 365-375. (Pubitemid 39390599)
51. Soucek, K., A. Kamaid, A.D. Phung, L. Kubala, J.C. Bulinski, R.W. Harper, et al. 2006. Normal and prostate cancer cells display distinct molecular profiles of α-tubulin posttranslational modifications. Prostate 66: 954-965. (Pubitemid 43849594)
52. Lafanechere, L., and D. Job. 2000. The third tubulin pool. Neurochem Research 25: 11-18. (Pubitemid 30074270)
53. Akan, I., S. Akan, H. Akca, B. Savas, and T. Ozben. 2005. Multidrug resistance-associated protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine sulfoximine. Cancer Cell International 5: 22.
54. Heng, H.H., J.B. Stevens, G. Liu, S.W. Bremer, and C.J. Ye. 2004. Imaging genome abnormalities in cancer research. Cell and Chromosomes 5: 22.
55. Kanda, N., H. Seno, Y. Konda, H. Marusawa, M. Kanai, and T. Nakajima. 2004. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 23: 4921-4929. (Pubitemid 38932164)
56. Wu, C., F. Chen, J.W. Rushing, X. Wang, H.J. Kim, G. Huang, et al. 2006. Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines. Journal of Medicinal Food 9: 55-61. (Pubitemid 44153618)
57. Wang, W., M. Adachi, R. Kawamura, H. Sakamoto, T. Hayashi, T. Ishida, et al. 2006. Parthenolide-induced apoptosis in multiple myeloma cells involves reactive oxygen species generation and cell sensitivity depends on catalase activity. Apoptosis 11: 2225-2235. (Pubitemid 44885398)
58. Gopal, Y.N., T.S. Arora, and M.W. Dyke. 2007. Parthenolide specifically depletes histone deacetylase 1 protein and induces cell death through ataxia telangiectasia mutated. Chemical Biology 14: 813-823. (Pubitemid 47081425)
59. Minucci, S., and P.G. Pelicci. 2006. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nature Reviews Cancer 6: 38-51. (Pubitemid 43054973)